Trials / Completed
CompletedNCT01089309
Effect of Aldosterone Blockade on Arterial Compliance
Effect of Aldosterone Blockade on Metabolic Parameters and Arterial Compliance
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 51 (actual)
- Sponsor
- Wolfson Medical Center · Other Government
- Sex
- All
- Age
- 45 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The present study investigated the long-term (12 months) effect of spironolactone treatment on glucose homeostasis, metabolic parameters and vascular properties.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Spironolactone | Spironolactone orally, at a dose of 50 mg/day for 12 months |
Timeline
- Start date
- 2004-05-01
- Primary completion
- 2007-06-01
- Completion
- 2007-06-01
- First posted
- 2010-03-18
- Last updated
- 2010-03-29
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT01089309. Inclusion in this directory is not an endorsement.